Buch

---

Übersicht

---

Verlag	:	Springer International Publishing
Buchreihe	:	Handbook of Experimental Pharmacology (Bd. 233)
Sprache	:	Englisch
Erschienen	:	20. 04. 2018
Seiten	:	469
Einband	:	Kartoniert
Höhe	:	235 mm
Breite	:	155 mm
Gewicht	:	8071 g
ISBN	:	9783319806570
Sprache	:	Englisch

---

Autorinformation

---

Stephan Herzig obtained his PhD from the University of Göttingen, Germany, in 1999. Supported by the German Research Foundation DFG he then joined the Salk Institute for Biological Studies, La Jolla, CA, for his postdoctoral training. In 2004, he established an Emmy-Noether and Marie Curie Junior Research Group at the German Cancer Research Center (DKFZ) in Heidelberg, Germany. He became Head of a Joint Research Division between the DKFZ, Heidelberg University, and Heidelberg University Hospital in 2010, followed by his appointment as a Full W3 Professor at the Medical Faculty of Heidelberg University. Since 2015, Stephan Herzig is the director of the Institute for Diabetesand Cancer (IDC) at the Helmholtz Center Munich and he holds the chair in Molecular Metabolic Control at the Technical University Munich as well as a Honorary Professorship at the Medical Faculty at Heidelberg University. Stephan Herzig studies the molecular mechanisms of severe metabolic disorders and their complications, including insulin resistance, type 2 diabetes, and cancer.

Inhaltsverzeichnis

---

1 Central nervous system control of metabolism.- 2 Glucocorticoids and metabolic control.- 3 Anti-lipidemic drugs.- 4 Genomics and metabolism.- 5 cAMP signaling.- 6 cGMP and brown adipose tissue.- 7 Inflammatory signaling and metabolism.- 8 Insulin signaling.- 9  Nuclear receptor co-factors in metabolism.- 10 Novel treatment options in diabetes.- 11 Adipose tissue stem cells.- 12 Adipokines.- 13 Immune cells and metabolism.- 14 Brown adipose tissue in humans.- 15 Diabetes and Cancer.- 16 Cancer Cell Metabolism.- 17 Incretins.

Deine Buchhandlung

---